11:02 AM EST, 02/13/2025 (MT Newswires) -- Lixte Biotechnology ( LIXT ) said Thursday it closed a registered direct offering of 434,784 shares at $2.415 apiece for about $1.1 million in gross proceeds.

The biotechnology company said it plans to use the net proceeds for working capital and other general corporate purposes.

Lixte also said it issued unregistered warrants in a concurrent private placement to acquire up to 434,784 shares, with each warrant exercisable at $2.29 per share.

Shares were down 2.4% in recent trading.

Price: 1.66, Change: -0.04, Percent Change: -2.35